Source: ODYSSEY OUTCOMES Investigators & Poulsen , S H 2024 , ' Safety of the PCSK9 inhibitor alirocumab : insights from 47 296 patient-years of observation ' , European heart journal - Cardiovascular

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.

Authors : Nakamura, Yoshiaki; Mizuno, Nobumasa; Sunakawa, Yu

Subjects: Trastuzumab; ERBB2 protein, human; tucatinib

Source: Journal of Clinical Oncology, 41 (36), 5569 - 5578 (2023-12-20)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.

Authors : Thaçi, D.; Vender, R.; de Rie, M.A.

Subjects: Humans; Adalimumab/therapeutic use; Antibodies

Source: The British journal of dermatology, vol. 188, no. 1, pp. 22-31

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts

Authors : Bhatt, Surya P; Rabe, Klaus F; Hanania, Nicola A

Subjects: Humans; Antibodies; Monoclonal

Source: Bhatt , S P , Rabe , K F , Hanania , N A , Vogelmeier , C F , Cole , J , Bafadhel , M , Christenson , S A , Papi , A , Singh , D , Laws , E , Mannent , L P , Patel , N , Staudinger , H W , Yancopoulos

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Re:Aducanumab-Related ARIA: Paean or Lament?

Authors : Hoilund-Carlsen, Poul F.; Alavi, Abass; Revheim, Mona Elisabeth

Subjects: Alzheimer Disease; Amyloid beta-Peptides; Antibodies

Source: Hoilund-Carlsen , P F , Alavi , A & Revheim , M E 2023 , ' Re : Aducanumab-Related ARIA: Paean or Lament? ' , Clinical Nuclear Medicine , vol. 48 , no. 6 , pp. 505-506 .

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Belantamab Mafodotin Related Keratopathy ; Queratopatia Relacionada com Belantamab Mafodotina

Authors : Sáenz Madrazo, Nerea; Baeza, Azucena; Encinas, Cristina

Subjects: Corneal Diseases/ chemically induced; Antibodies; Monoclonal

Source: Revista Sociedade Portuguesa de Oftalmologia; Vol. 47 No. 2 (2023); 139-140 ; Revista Sociedade Portuguesa de Oftalmologia; Vol. 47 N.º 2 (2023); 139-140 ; 1646-6950

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Lecanemab in Early Alzheimer's Disease

Authors : van Dyck, Christopher H; Swanson, Chad J; Aisen, Paul

Subjects: Humans; Activities of Daily Living; Alzheimer Disease (diagnostic imaging

Source: Neurology

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Design of a phase 3, randomized, double-blind, placebo-controlled, 48-week study to evaluate the efficacy and safety of cendakimab in adult and adolescent patients with eosinophilic esophagitis.

Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma.

Safety of the PCSK9 inhibitor alirocumab:insights from 47 296 patient-years of observation

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.

Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts

Re:Aducanumab-Related ARIA: Paean or Lament?

Belantamab Mafodotin Related Keratopathy ; Queratopatia Relacionada com Belantamab Mafodotina

Lecanemab in Early Alzheimer's Disease

اتصل بنا

اتبع